LLY Related Company Press Releases

May 14, 2013 04:30 PM Lilly Oncology to Release New Pipeline Data at ASCO 2013

May 14, 2013 09:00 AM Lilly Provides Update on CEO Dr. John Lechleiter

May 10, 2013 08:00 AM Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma

May 6, 2013 06:38 PM Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress

May 6, 2013 04:30 PM Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery

May 6, 2013 02:30 PM Lilly Declares Second-Quarter 2013 Dividend

May 2, 2013 08:00 AM Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes

May 1, 2013 02:58 PM The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies – Big or Small

May 1, 2013 01:00 PM The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small

Apr 30, 2013 08:00 AM Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration

Apr 26, 2013 07:00 AM Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams

Apr 24, 2013 11:00 AM Lilly Again Named One of DiversityInc's Top 50 Companies for Diversity

Apr 24, 2013 06:30 AM Lilly Reports First-Quarter 2013 Results

Apr 17, 2013 08:00 AM Lilly Acquires Novel Tau Tangle Diagnostic Program to Bolster Alzheimer's Disease Research and Development

Apr 16, 2013 08:05 AM Lilly Announces Positive Results of Phase III Trials of Dulaglutide in Type 2 Diabetes

Apr 10, 2013 08:00 AM Lilly Debuts Early Oncology Pipeline Data At AACR Annual Meeting

Apr 4, 2013 08:50 AM Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures

Apr 3, 2013 04:23 PM Lilly Confirms Date and Conference Call for First-Quarter 2013 Financial Results Announcement

Apr 2, 2013 08:00 AM Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations

Mar 26, 2013 11:23 AM European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Company's empagliflozin*, an investigational type 2 diabetes treatment

Mar 25, 2013 08:00 AM American College of Endocrinology (ACE) to emphasize emergency planning for people with diabetes at National Hurricane Conference

Mar 25, 2013 08:00 AM Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment